| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |